Member Info for gameangler

https://twitter.com/Stockonomist/status/1252526918496378880?s=20

Christmas may come very early this year.
Avacta will attract some serious attention to their affirmer platform, expect £5 take out ?????????

https://seekingalpha.com/article/4337487-basket-of-5-small-cap-gold-stocks-average-4_4x-2020-p-e-and-1_93x-ev-ebitda

https://seekingalpha.com/article/4337487-basket-of-5-small-cap-gold-stocks-average-4_4x-2020-p-e-and-1_93x-ev-ebitda

Market seems to appreciate Robert W. Duggan taking over from Glyn Edwards as CEO.
A proven winner at last taking over from a proven failure who took the share down from 200+ p to below 20p.
Summit up 28% today to US $4.20
https://www.nasdaq.com/market-activity/stocks/smmt

Good progress up 23% today to US $3.28
1 month rise 42%
3 month rise 85%

Cytiva is the first client for this affirmer.

Avacta are advising it may be ....' potentially on the platforms of other partners with whom we are in active discussion, as soon as possible'

Steady follow of good news on the horizon
https://ir.etonpharma.com/news-releases/news-release-details/eton-pharmaceuticals-announces-acquisition-us-marketing-rights

Seeking Alpha today :Summit Therapeutics (NASDAQ:SMMT) resumed with Buy rating and $4 (46% upside) price target at H.C. Wainwright.
SMMT on NASDAC today $2.67 for ADR (5 shares).
At current rate 1.15/1 $/£ this equates to 46p per share
New price target $ 4.00 is £3.48 or 70p per share
Trust my maths are correct. There has been a big rise in last few days

Beauty of this share is that it has developed a platform to launch innovative alternatives into the huge and lucrative antibody area.
The way I see it, it is difficult to estimate a future share price because there are so many collaborations starting with large pharma. Revenue growth depends on the successful progression of the drug approval processes.
Big money payoffs from these would probably be more than 2-3 years away.
If on the other hand, the use of preCISION tumour activated chemotherapy has a successful PHASE 1 trial this year, it will be a massive boost for AVACTA. If after 2-3 years, they were not well on the way to a £1bn company it would be very surprising. They would also be highly attractive to a predator.

From a week ago

https://www.edisongroup.com/publication/tulu-kapi-project-started-and-financings-improved/26282/

IMPRESSIVE
https://bioview.com/

In November 2019 AVACTA had a fund raise involving 60m new shares at 15p. This increased shares in issue from 116m to 176m.
Whilst most would be taken by existing institutions, some new private investors may have been unable to resist a 100% return in 3 months. Hence some selling of shares, though the volumes of sells over buys is low.

Given a steady flow of new good news, it is only a matter of time before this takes off.

Persistence pays off, how much , we will find out soon.
Happy times for long term shareholders.

https://www.sharesmagazine.co.uk/video/mark-reid-ceo-sdx-energy-sdx

If you spread yourself too thinly you achieve nothing.
We are a rapidly contracting micro cap. with very limited finances.
Surely we need to focus on developing our best risk/reward project. We can park the others for the time being, while we are still solvent.

Would not expect HUM to get involved with developing Dugbe.
As gold rises the economics of Dugbe will improve significantly.
There should then be a number of mid-caps (or Chinese) willing to open their cheque books. There cannot be many +4 moz gold projects with a mining licence and large exploration upsides available.
Patience can be very rewarding.

A posting on SeekingAlpha with some concerns about the clarity of communications to shareholders.

Stockpiling of lower grade ores to blend with forthcoming higher grade ore ( Gonka) is not unusual.
My view is that the cash flow in the next 2 years should resolve any financial concerns on the balance sheet.

https://seekingalpha.com/article/4319324-hummingbird-delivers-in-q4-2019-out?dr=1&utm_medium=email&utm_source=seeking_alpha

For Dugbe, I think this is a tremendous asset to own in the current period of rising demand for gold.
4.2 moz in Resources and a further + 2,000 sq/km of highly prospective licence to explore.
In Europe with 2% Inflation and minus 0.5% interest you are losing 2.5% of your deposits pa in real terms. This is one of the reasons for the revived interest in gold.
The takeaway from Davos was that Central Bankers agreed that Quantitative Easing was no longer effective . Governments needed to support their economies with fiscal measures ie public spending on infrastructure projects. That invariably has led to higher inflation and fuelled a strong bull market in gold.

I also have concerns of a sale to to an unknown BVI company.
I was talking a few days ago to a successful private equity principal. He stressed that business fraud is running rampant at the moment as it is seen as a unpunished crime. You have to be very careful.
Resource companies who have spent a large some of money developing an asset can pass control to an organisation for follow on investing. The new owners have control . They can sell assets, run it into bankruptcy and the previous owner cannot recover it as they are not a creditor, just minority shareholder.
We need to know why we have to now sell this asset now when rising gold should passively and risk free raise its potential value.

In 29th Nov interview they laid out their future plans.
Their Vulcan fine crome project will mop up their current $60m cash so they are looking at funding options.

They have plans for two large projects in crome and diamonds in Zimbabwe for which they will need funding.
Watch out for a potentially dilutive fund raising.

This could be a very high risk investment strategy. There is a long history of enticing investment into Zimbabwe, and then expropriating it. Recent mining expert advice is to tread slowly and carefully. do not be blinded by greed and risk your shareholders money.

Every successful investor always fears the words.....'This time it is different'..!!!

Until fund raising risks are are clearly apparent, Tharisa should be treated with caution.

There appears to be an oversupply of crome and uneconomic selling prices. When some high cost mines shut down there will be a recovery in profits. Given PGM profits are strongly growing , crome miners who recover their pgms will be the winners. They will reap the benefits when the supply /demand situation reverses, his includes Tharisa

They are a South African mining operation, and process both crome and pgms.
Their comments are interesting on crome and pgm basket prices, and power outages. Their Rhodium % is normally around 10% which is quite high.
Tharisa stripping ratio is 11:1, and Jubilee materials are tailings on the surface.

Thanks for your comments dropinmonkey, I agree that there is lack of clarity by Humm reporting to shareholders.

They must have their own costs outside the Yanfolila project, that are lumped in the Company accounts eg Dugbe and maintenance of licences and buildings/offices etc in Liberia. Also corporate overheads ,listing fees etc.
Lack of information could lead potential shareholders to think that they do not want shareholders to know something.

Still potentially a good investment and if gold keeps rising, Dugbe may be worth a significant sum. I understand there were large areas that were highly prospective but not extensively drilled. A bigger resource could fundamentally change the economics by justifying building a hydroelectric scheme.